Gerrit Jansen

14.8k citations
333 papers · 11.5k · 1 hit paper · h-index 58

Impact in

  • Rheumatology top 0.2%
    • Folate and B Vitamins Research
  • Oncology top 0.5%
    • Drug Transport and Resistance Mechanisms

Papers in

    • Ubiquitin and proteasome pathways 34
    • Biochemical and Molecular Research 22
    • Protein Degradation and Inhibitors 19
    • Folate and B Vitamins Research 62
    • Rheumatoid Arthritis Research and Therapies 31

Gerrit Jansen

322 papers receiving 11.2k citations

Gerrit Jansen's Hit Papers

MRP3, an organic anion transporter able to transport anti-cancer drugs 1999 · 524 citations
5240+9+18Years since publication100200300400500

Peers

Gerrit Jansen
Comparison fields: 5 of 147
  • Rheumatology 2.1k
  • Oncology 3.6k
  • Hematology 1.5k
  • Molecular Biology 4.7k
  • Cancer Research 844
Replace Larry H. Matherly with:
Larry H. Matherly United States
George L. Scheffer Netherlands
Hisahiro Yoshida Japan
David W. H. Riches United States
Edward D. Harris United States
A. V. Hoffbrand United Kingdom
Michelle Haber Australia
Hidekazu Tsukamoto United States
Susan P.C. Cole Canada
Theo J.C. van Berkel Netherlands
Gerrit Jansen relative to Larry H. Matherly United States Larry H. Matherly's profile →
Citations per field
00.5×3.2×
Larry H. Matherly · 1×
Citations per year

Countries citing papers authored by Gerrit Jansen

Since Specialization
Citations

This map shows the geographic impact of Gerrit Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerrit Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerrit Jansen more than expected).

Fields of papers citing papers by Gerrit Jansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerrit Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerrit Jansen. The network helps show where Gerrit Jansen may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerrit Jansen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerrit Jansen Line = papers co-authored together Gerrit Jansen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 333 papers — load more, or switch the sort, to bring in the rest.

#Work
1
MRP3, an organic anion transporter able to transport anti-cancer drugs
Hit paper breakdown →
1999524
2
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
1999361
3 2008358
4 2002334
5 2011292
6 2020194
7 2017185
8 1996167
9 2014155
10 1998147
11 2011137
12 2003132
13 2017130
14 2008129
15
Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.
1999126
16 2008124
17 2017113
18 1999110
19 2005110
20 1999109

About Gerrit Jansen

Gerrit Jansen is a scholar working on Molecular Biology, Rheumatology, Oncology, Public Health, Environmental and Occupational Health and Hematology, having authored 333 papers that have together received 11.5k indexed citations. Recurring topics across this work include Folate and B Vitamins Research (62 papers), Acute Lymphoblastic Leukemia research (52 papers), Drug Transport and Resistance Mechanisms (40 papers), Ubiquitin and proteasome pathways (34 papers), Rheumatoid Arthritis Research and Therapies (31 papers), Chronic Myeloid Leukemia Treatments (26 papers), Biochemical and Molecular Research (22 papers) and Protein Degradation and Inhibitors (19 papers). The work is most often cited by research in Rheumatology (2.1k citations), Oncology (3.6k citations), Hematology (1.5k citations), Molecular Biology (4.7k citations) and Cancer Research (844 citations). Gerrit Jansen has collaborated with scholars based in Netherlands, United States and Israel. Frequent co-authors include Godefridus J. Peters, Yehuda G. Assaraf, Gertjan J.L. Kaspers, Jacqueline Cloos, Rik J. Scheper, George L. Scheffer, Jan H. Schornagel, Ietje Kathmann, Paul Noordhuis and Jan Hendrik Hooijberg. Their work appears in journals such as Blood, Annals of the Rheumatic Diseases, Journal of Nutrition, Biochemical Pharmacology and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact